Kaplan-Meier analysis shows PFS and OS in advanced lung cancer, suggesting immunotherapy may improve outcomes.
Supplementary Figure 3. Kaplan-Meier estimation of PFS and OS in SCLC with immunotherapy or not.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: